The frequencies of intra-tumor CD4+CD25+Foxp3+ T cells in animals treated only with naringenin did not show any significant difference; showing that CPT but not naringenin was able to modulate intratunoral Tregs. The gene discussed is CD4; the disease is neoplasm.